Connection

Till Bärnighausen to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Till Bärnighausen has written about Cost-Benefit Analysis.
Till Bärnighausen
Connection Strength
0.129
Cost-Benefit Analysis
  1. Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints. PLoS Med. 2017 02; 14(2):e1002240.
    View in: PubMed
    Score: 0.081
  2. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Trials. 2021 Jan 08; 22(1):39.
    View in: PubMed
    Score: 0.027
  3. Impact of early initiation versus national standard of care of antiretroviral therapy in Swaziland's public sector health system: study protocol for a stepped-wedge randomized trial. Trials. 2017 08 18; 18(1):383.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.